Esco Aster spinoff transactions
We are advising Esco Lifesciences on the spinoff
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
InSilico Medicine $35 million Series D2 financing
We are advising InSilico Medicine on the financing
Taibang Biologic Group $300 million equity raising
We are advising Taibang Biologic Group in connection with its equity raising by a group of investors
Tencent renewed strategic cooperation with JD.com
We are advising Tencent on the renewal of the strategic cooperation agreement and purchase of ordinary shares of JD.com
InSilico Medicine $60 million Series D financing
We are advising InSilico Medicine in connection with its $60 million Series D financing
Jeeves $180 million Series C equity financing round
We advised Tencent as lead investor in the new round
Provident Acquisition $1.02 billion combination with Perfect
We are advising Provident Acquisition, a SPAC, on the transaction
Academia.edu $23 million Series D funding round
We advised Tencent as lead investor in the Series D investment
Carsome Group $290 million Series E funding round
We are advising Carsome on its Series E funding round
Blue Safari Group merger with Bitdeer Technologies
We are advising Blue Safari on the transaction